rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1998-7-6
|
pubmed:abstractText |
The 5-year survival rate following surgical resection of Stage I or Stage II non-small cell lung carcinoma (NSCLC) is 30% to 50%, probably because of undetected occult micrometastases (OMs) at the time of surgery. Other investigators have detected OMs in bone marrow and histologically negative lymph nodes from patients with NSCLC using immunohistochemical staining to cytokeratins and cell surface glycoproteins.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0012-3692
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
113
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1526-32
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:9631789-Adult,
pubmed-meshheading:9631789-Aged,
pubmed-meshheading:9631789-Aged, 80 and over,
pubmed-meshheading:9631789-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:9631789-Female,
pubmed-meshheading:9631789-Humans,
pubmed-meshheading:9631789-Immunohistochemistry,
pubmed-meshheading:9631789-Lung Neoplasms,
pubmed-meshheading:9631789-Lymph Nodes,
pubmed-meshheading:9631789-Lymphatic Metastasis,
pubmed-meshheading:9631789-Male,
pubmed-meshheading:9631789-Middle Aged,
pubmed-meshheading:9631789-Mucin-1,
pubmed-meshheading:9631789-Polymerase Chain Reaction,
pubmed-meshheading:9631789-RNA, Messenger,
pubmed-meshheading:9631789-RNA-Directed DNA Polymerase,
pubmed-meshheading:9631789-Sensitivity and Specificity
|
pubmed:year |
1998
|
pubmed:articleTitle |
Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction.
|
pubmed:affiliation |
Department of Surgery, University of Minnesota, Minneapolis V.A. Medical Center, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|